Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Sheng Ding

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|March 18, 2026
Letter: Steroid Tapering-Is Shorter Duration Better?Juntao Lu, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|September 19, 2024
Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial dataJohn David Chetwood, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|September 17, 2025
Editorial: Managing the Moving Target-Dose Adjustments in Inflammatory Bowel DiseaseNicholas Clark, Daniel Tassone, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinibDaniel Tassone, Siddharth Singh, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|September 13, 2023
Letter: Muscle thickness measurement using ultrasound-A step closer to the use of body composition analysis in the management of inflammatory bowel diseaseDaniel Tassone, Imogen Hartley, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|July 15, 2023
Letter: Combatting sarcopenia to improve clinical outcomes in inflammatory bowel diseaseDaniel Tassone, Imogen Hartley, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|February 13, 2024
Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment erasDaniel Tassone, Imogen Hartley, Nik Sheng Ding
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Prevention of COVID-19 in patients with IBD - Authors' replyNik Sheng Ding, Ping An, Weiguo Dong, et al.
RMD Open|May 16, 2022
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)Ai Phuong Tran, Daniel Tassone, Johannes Nossent, et al.
Journal of Digestive Diseases|June 16, 2025
Outcomes of Fecal Diversion in Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisImogen Hartley, Babak Sarraf, Helen Wilding, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|March 18, 2026
Letter: Steroid Tapering-Is Shorter Duration Better?Juntao Lu, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|September 19, 2024
Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial dataJohn David Chetwood, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|September 17, 2025
Editorial: Managing the Moving Target-Dose Adjustments in Inflammatory Bowel DiseaseNicholas Clark, Daniel Tassone, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinibDaniel Tassone, Siddharth Singh, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|September 13, 2023
Letter: Muscle thickness measurement using ultrasound-A step closer to the use of body composition analysis in the management of inflammatory bowel diseaseDaniel Tassone, Imogen Hartley, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|July 15, 2023
Letter: Combatting sarcopenia to improve clinical outcomes in inflammatory bowel diseaseDaniel Tassone, Imogen Hartley, Nik Sheng Ding
Alimentary Pharmacology & Therapeutics|February 13, 2024
Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment erasDaniel Tassone, Imogen Hartley, Nik Sheng Ding
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Prevention of COVID-19 in patients with IBD - Authors' replyNik Sheng Ding, Ping An, Weiguo Dong, et al.
RMD Open|May 16, 2022
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)Ai Phuong Tran, Daniel Tassone, Johannes Nossent, et al.
Journal of Digestive Diseases|June 16, 2025
Outcomes of Fecal Diversion in Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisImogen Hartley, Babak Sarraf, Helen Wilding, et al.
Pageof 3